Sight Sciences: Final Medicare LCDs confirm coverage for OMNI and SION procedures but impose usage limitations

Sight Sciences, Inc.

Four MACs (Palmetto GBA, CGS, NGS, WPS) published final LCDs effective Nov 17, 2024, confirming coverage for single MIGS with phaco.
Coverage continues for canaloplasty/trabeculotomy (OMNI) and goniotomy (SION) procedures.
Limitations: non-coverage for first-line mild-to-moderate glaucoma, combined MIGS with aqueous shunt, and phaco with multiple MIGS.
Sight Sciences plans to engage with MACs, CMS, and clinical societies on coverage issues.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.